Bloomstandard

1 known investors

Bloom Standard develops RAPIDscan, an autonomous, hands-free ultrasound system with AI-driven onboard image interpretation to detect cardiac and lung abnormalities in newborns, children, and maternal patients. The device targets maternity, primary care, and under-resourced or humanitarian health settings, enabling use by non-specialist operators and integration with existing health systems.